Remegen Co. Ltd. Class ASSE: 688331

Announcement on Signing a Licensing Agreement with AbbVie

· Issued by Remegen Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Signing a Licensing Agreement with AbbVie

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment